Click Therapeutics

Click Therapeutics, Inc. is a healthcare software company based in New York City, founded in 2012. The company specializes in developing, validating, and commercializing software as prescription medical treatments, focusing on Digital Therapeutics™ that promote behavioral change through cognitive and neurobehavioral mechanisms. These digital treatments can be used independently or alongside traditional therapies. The company's core technology, Clickometrics®, is an adaptive data science platform that personalizes user experiences to enhance patient engagement and treatment outcomes. Click Therapeutics has created a leading smoking cessation program that is available nationwide and has successfully completed clinical trials. Additionally, the company is advancing a prescription digital therapeutic for Major Depressive Disorder (MDD), which is currently in late-stage clinical trials. Click Therapeutics serves a diverse range of customers, including healthcare payers, providers, employers, and patients with unmet medical needs. The company has raised over $144 million to support its initiatives and employs around 150 people.